Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Conditions: Febrile Neutropenia Interventions: Drug: Ceftolozane-Tazobactam; Drug: Meropenem Sponsors: Benefic ência Portuguesa de São Paulo; Merck Sharp& Dohme LLC Not yet recruiting

https://clinicaltrials.gov/study/NCT06342115

Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

More News: Merck | Research